Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
A-1210477: A Strategic MCL-1 Inhibitor Playbook
2026-09-19
A mechanistic and translational guide to using A-1210477 to interrogate MCL-1-dependent cancer cell survival, mitochondrial apoptosis, combination responses, and the limits of preclinical interpretation.
-
Epalrestat: Linking Polyol Flux to Nrf2 Assays
2026-09-18
Epalrestat is an aldose reductase inhibitor with a distinctive research profile spanning polyol pathway inhibition and KEAP1/Nrf2 biology. This article presents an assay-centered framework for separating metabolic effects from neuroprotective mechanism in diabetic neuropathy research and Parkinson’s disease models.
-
AZD0156: Designing Better ATM Inhibitor Assays
2026-09-18
AZD0156 is a selective ATM kinase inhibitor for dissecting DNA damage response and metabolic vulnerabilities. This guide translates evidence from high-grade serous ovarian cancer research into practical assay-design decisions, emphasizing combination logic, senescence readouts, and experimental interpretation.
-
Ginsenoside Rg1: Reliable Assay Workflows
2026-09-17
Learn how Ginsenoside Rg1, SKU N1613, can support more interpretable cell viability, cytotoxicity, apoptosis, and neuroimmune experiments. This scenario-based guide connects solubility, study parameters, assay controls, and supplier-quality decisions to practical laboratory workflows.
-
Nuclear PI3P Connects Vps34 to DNA Mismatch Repair
2026-09-17
The reference study identifies nuclear phosphatidylinositol-3-phosphate (PI3P), generated by the Beclin-1/Vps34 complex, as a functional cofactor for DNA mismatch repair. Its findings connect lipid signaling with MutSα and MutSβ assembly, DNA binding, microsatellite stability, and DNA damage responses through an autophagy-independent mechanism.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-16
This 2024 Bioorganic Chemistry study developed spirocyclic phenyl oxazole methyl derivatives and identified compound 5c as an active anti-tubercular lead against Mycobacterium tuberculosis and drug-resistant clinical isolates. Genetic resistance mapping, docking, ADME, pharmacokinetic, and THP-1 cytotoxicity data together support MmpL3 as the likely target and provide a foundation for further optimization.
-
DOPE Workflows for Delivery and Fungal Assays
2026-09-16
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is both an endosomal-fusion helper for nucleic acid delivery and a practical phosphatidylethanolamine rescue reagent for fungal developmental assays. This guide connects formulation, conidial ferroptosis experiments, solvent handling, and troubleshooting without treating a rescue result as proof of a single molecular target.
-
CP-673451: ATRX-Aware PDGFR Research Strategy
2026-09-15
CP-673451 is a selective PDGFRα/β inhibitor for connecting receptor engagement with ATRX-aware glioma, angiogenesis, and xenograft experiments. This article presents a genotype-informed assay strategy that separates direct target inhibition from downstream tumor phenotypes.
-
3D Collagen Microtissues for Cancer Drug Testing
2026-09-15
The reference study adapts modular tissue engineering to create free-floating collagen microtissues containing triple-negative breast cancer cells. These constructs reproduced hypoxia, stemness-associated phenotypes, and clinically relevant treatment resistance while remaining comparatively practical to fabricate, offering a useful bridge between conventional monolayers and more complex tumor models.
-
Structure-Based NSP15 Inhibitor Discovery
2026-09-14
The reference study used structure-based virtual screening and molecular dynamics to prioritize natural products against the SARS-CoV-2 endoribonuclease NSP15. Thymopentin and oleuropein formed the most stable computationally predicted complexes, providing a rational starting point for biochemical validation rather than evidence of clinical antiviral efficacy.
-
Cas9 mRNA for Mechanistic Neurodegeneration Research
2026-09-14
A translational framework for using EZ Cap™ Cas9 mRNA (5-moUTP) in CRISPR-Cas9 genome editing studies informed by evidence connecting Fyn, Stat3, NF-κB, microglia activation, and dopaminergic neuron loss in zebrafish. The article distinguishes biological evidence from product-specific claims and outlines a disciplined path from target validation to preclinical research.
-
Rhodamine 123: From Efflux Signal to Translation
2026-09-13
Rhodamine 123 is more than a fluorescent readout: it is a live-cell lens on transporter biology. This thought-leadership article explains how Rhodamine 123 (chloride) can strengthen ABCB1/MDR1 studies, contextualize ABCG2-focused findings such as marein-mediated chemosensitization, and guide translational assay design without overstating what fluorescence alone can prove.
-
LACTB, Mitochondrial Remodeling, and Apoptosis
2026-09-12
Kamerkar and colleagues identify LACTB as a regulator of apoptosis-induced inner mitochondrial membrane remodeling, linking a tumor-suppressive protein to cytochrome c mobilization without altering BAX or Drp1 recruitment. Their cell-based, imaging, biochemical, and membrane-reconstitution experiments suggest that LACTB acts at the cristae-remodeling stage of apoptosis and provide a framework for separating outer-membrane permeabilization from downstream mitochondrial architecture.
-
Epalrestat: Aldose Reductase Inhibitor Workflows
2026-09-11
Epalrestat supports mechanism-driven studies spanning polyol pathway inhibition, diabetic neuropathy research, and neuroprotection in Parkinson’s disease models. This practical guide covers stock preparation, assay design, KEAP1/Nrf2 validation, and troubleshooting for reproducible oxidative stress research.
-
Alternariol Workflows for Mycotoxin Research
2026-09-11
Use AOH as a controlled probe for hepatic stellate-cell activation, apoptosis, cytoskeletal disruption, and cytochrome P450 metabolism. This practical guide combines reproducible dosing, mechanism-focused controls, and troubleshooting strategies for translating Alternaria toxin findings into defensible assays.